The injection is approved in combination with plasma exchange and immunosuppressive therapy for adults with acquired thrombotic thrombocytopenia...
But the clinical significance of this finding is unclear because of the lack of data on bleeding symptoms, according to authors of the meta-...
Patients with generalized nonthymomatous myasthenia gravis who undergo thymectomy may have better long-term clinical outcomes and require less...
The highest-risk AEDs were zonisamide, rufinamide, clorazepate, lamotrigine, carbamazepine, and phenytoin.
News from the FDA/CDC
The central nervous system depressant was approved for the treatment of cataplexy and excessive daytime sleepiness.
MS relapse can have a significant impact on patients’ short- and long-term function, quality of life, and finances. Here’s what to look for—and...
A pivotal phase 2/3 trial of bertilimumab will begin next year, according to the company.